New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Abbott earns approval for a hepatitis C genotyping test. EDAP gets CE mark for its robotic HiFU prostate cancer device. More product news.
You may also be interested in...
EDAP Will Go To FDA Panel In July For HIFU Prostate Cancer Device
Data for the French firm’s Ablatherm-HIFU for treating localized prostate cancer will be discussed by the agency’s Gastroenterology and Urology Device Panel this summer.
People In Brief
Allergan gains new president; Multiplicom appoints chairman; NxStage names new CFO; more personnel news.
Silicone Breast Implant Approvals Conditioned On Huge Postmarket Studies
FDA's Nov. 17 approval of silicone-gel breast implants comes with the requirement for one of the largest post-approval studies ever called for by the device center, according to CDRH Director Dan Schultz